Zobrazeno 1 - 10
of 400
pro vyhledávání: '"Fruquintinib"'
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 18, Pp 5203-5210 (2024)
Sebawe Syaj, Anwaar Saeed Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USACorrespondence: Anwaar Saeed, Division of Hematology-Oncology, Department of Medicine, University of Pi
Externí odkaz:
https://doaj.org/article/81a7a82191fe489e8202928fcdaf1407
Autor:
Chenchen Yang, Binghao Li, Sen Dong, Jie Xu, Xin Sun, Xin Liang, Kuisheng Liu, Kunkun Sun, Yi Yang, Tao Ji, Zhaoming Ye, Lu Xie, Xiaodong Tang
Publikováno v:
Orthopaedic Surgery, Vol 16, Iss 10, Pp 2380-2390 (2024)
Objective Multitargeted tyrosine kinase inhibitors (TKIs) have been approved as second‐line therapy in refractory sarcoma, prolonging progression‐free survival (PFS) but with short‐lived duration of disease control. Fruquintinib is a TKI that s
Externí odkaz:
https://doaj.org/article/6e10ca5a8ca043a29aa4365dc80597b6
Publikováno v:
PeerJ, Vol 12, p e18565 (2024)
Objective Fruquintinib, a novel anti-angiogenic targeted drug, has gained widespread application in the treatment of metastatic colorectal cancer. This study aims to investigate the impact of the prognostic nutritional index (PNI) on the safety and s
Externí odkaz:
https://doaj.org/article/535b5dba94bc4c24bbc0cf2a6cea6731
Autor:
Kanglian Zheng, Xu Zhu, Liang Xu, Guang Cao, Chuanxin Niu, Xiaoluan Yan, Da Xu, Wei Liu, Quan Bao, Lijun Wang, Kun Wang, Baocai Xing, Xiaodong Wang
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Background and aimThe prognosis of microsatellite stable (MSS)-colorectal cancer liver metastasis (CRCLM) following failure of multi-line therapy remains dismal. The aim of this study is to evaluate the efficacy and safety of hepatic arterial infusio
Externí odkaz:
https://doaj.org/article/a140f0ff9a6a44ba9de682271fd62f24
Publikováno v:
Cancer Medicine, Vol 13, Iss 13, Pp n/a-n/a (2024)
Abstract Background The purpose of this study was to evaluate the efficacy and safety of fruquintinib‐based therapy as a salvage therapy for patients with advanced or metastatic sarcoma, including soft tissue sarcoma (STS) and bone sarcoma. Methods
Externí odkaz:
https://doaj.org/article/3bd4c94f0a43484b95254fe43175254a
Publikováno v:
Zhongliu Fangzhi Yanjiu, Vol 50, Iss 12, Pp 1227-1231 (2023)
Objective To investigate the clinical efficacy and safety of fruquintinib combined with sintilimab in the treatment of advanced microsatellite stable (MSS) colorectal cancer. Methods A retrospective study of 44 patients with MSS colorectal cancer tre
Externí odkaz:
https://doaj.org/article/7a08ffa028984281ab59549a193d4fcb
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 22038-22046 (2023)
Abstract Background Fruquintinib has demonstrated significant improvement in overall survival (OS) among previously treated metastatic colorectal cancer (mCRC) patients. However, the utilization of fruquintinib has been constrained by various toxicit
Externí odkaz:
https://doaj.org/article/dec86540cc4e4b57945818b50db56fa8
Publikováno v:
Zhongguo quanke yixue, Vol 26, Iss 18, Pp 2262-2267 (2023)
Background The incidence of colorectal cancer is high, and metastatic colorectal cancer has entered a new era of targeted immunotherapy. Due to the limited choices of effective later-line treatment and the substantial reduction of physical quality ca
Externí odkaz:
https://doaj.org/article/c021a94b72de4b72a913a870e488c61c
Autor:
Wensi Zhao, Jun Lei, Shaobo Ke, Yuan Chen, Jiping Xiao, Ze Tang, Li Wang, Yiping Ren, Mohammed Alnaggar, Hu Qiu, Wei Shi, Lei Yin, Yongshun Chen
Publikováno v:
EClinicalMedicine, Vol 66, Iss , Pp 102315- (2023)
Summary: Background: Immunotherapy has revolutionized the treatment of cancer. However, microsatellite stable (MSS) metastatic colorectal cancer (mCRC) shows a low response to PD-1 inhibitors. Antiangiogenic therapy can enhance anti-PD-1 efficacy, bu
Externí odkaz:
https://doaj.org/article/82637cef24b148a3a2c88f91ff67caf0
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/5bc119eab61947b4917dfff1dfd3a809